Market Cap
$10.1B
BIO
BIO-RAD LABORATORIES, INC.
$369.14 ▲ +3.82%
Prev close $355.57Market cap$10.1B
ConsensusHold
12-mo target$328.33 (-11.1%)
▲ Neutral
Analyst conviction 5/10
26 New Institutional Positions23 Institutional Exits Industrials & Manufacturing
Snapshot
The big-picture read on BIO right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (50%)
Inst. Holders
50 funds
Inst. Value
$4.7B
Inst. Activity
26 buys / 23 sells
Social Sentiment
50° Neutral
SEC Reports
2
Price chart 30d -4.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 12, 2026 SEC
The court granted Brandeis University leave to file a Second Amended Complaint against Bio-Rad, allowing new allegations
COURT-RULING — Impact 5/10
Sep 10, 2026 ftd
FTD: BIO — 2,061 shares ($0.8M) failed to deliver
Settlement: 20260910, Price: $376.97, FTD Value: $776,935.17, BIO-RAD LABS CL A
Sep 10, 2026 Event
Brandeis University v. Bio-Rad Laboratories, Inc.
Court ruling (mad) — Docket: 1:25-cv-12780
Sep 6, 2026 Insider
BARRY JAMES acquired via exercise 1,056 shares
EVP, President, LSG
Sep 6, 2026 Insider
Allison Schwartz acquired via exercise 92 shares
Director
Sep 6, 2026 Insider
Allison Schwartz surrendered for taxes 34 shares
Director @ $386.11 ($13.1K)
Jun 30, 2026 Inst.
NOMURA HOLDINGS INC — ADD
328,897 shares ($96.6M)
Jun 30, 2026 Inst.
Assenagon Asset Management S.A. — ADD
233,227 shares ($68.5M)
Analyst ratings buy % -16.7%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
50% rate it Buy or better · 10 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 7, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Aug 5, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Aug 5, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Aug 5, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| May 1, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Apr 7, 2026 | Citigroup | DOWNGRADE | Neutral | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 1 | 4 | 4 | 1 | 0 | 50% | |
| Aug 1, 2026 | 1 | 4 | 4 | 1 | 0 | 50% | |
| Jul 1, 2026 | 1 | 4 | 4 | 1 | 0 | 50% | |
| Jun 1, 2026 | 1 | 4 | 4 | 1 | 0 | 50% | |
| May 1, 2026 | 1 | 4 | 5 | 0 | 0 | 50% | |
| Apr 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Mar 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Feb 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% |
Price targets
Where 3 covering analysts think BIO trades over the next 12 months.
$328.33 -11.1% upside Sell
Current$369.14 Low$280.00 Median$315.00 High$390.00 3 analysts
$280.00$390.00
Analyst rating Hold· 3.0/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
2 SEC filing reports analyzed · 0 bullish, 1 bearish, 1 mixed, 0 neutral · avg impact 5.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 10, 2026
ftd
FTD: BIO — 2,061 shares ($0.8M) failed to deliver
Settlement: 20260910, Price: $376.97, FTD Value: $776,935.17, BIO-RAD LABS CL A
Sep 10, 2026
Enforcement
Brandeis University v. Bio-Rad Laboratories, Inc.
Court ruling (mad) — Docket: 1:25-cv-12780
Sep 7, 2026
dark_pool
Dark Pool: BIO — 0.3M shares, 16,927 trades
Week starting 2026-09-07. Total ATS volume: 275,447 shares across 16,927 trades.
Sep 3, 2026
ftd
FTD: BIO — 4,193 shares ($1.6M) failed to deliver
Settlement: 20260903, Price: $388.51, FTD Value: $1,629,022.43, BIO-RAD LABS CL A
Aug 31, 2026
dark_pool
Dark Pool: BIO — 0.3M shares, 17,048 trades
Week starting 2026-08-31. Total ATS volume: 293,031 shares across 17,048 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $2.23 | $2.16–$2.29 | -1.6% | -0.3% | 0↑ 3↓ | $0.6B | 2 |
| Next Q | $3.02 | $2.74–$3.30 | 20.3% | +3.9% | 1↑ 2↓ | $0.7B | 2 |
| Current FY | $9.45 | $8.85–$10.10 | -4.7% | -0.3% | 4↑ 0↓ | $2.6B | 3 |
| Next FY | $9.92 | $8.75–$11.41 | 4.9% | -1.1% | 4↑ 0↓ | $2.6B | 3 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $2.225 | — |
| 7d ago | $2.231 | -0.006 |
| 30d ago | $2.231 | -0.006 |
| 60d ago | $2.311 | -0.086 |
| 90d ago | $2.311 | -0.086 |
Institutional ownership
Which big funds own BIO (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $4.7B total value (16,045,726 shares) as of 2026-Q2. Top holders: First, BlackRock,, DIMENSIONAL. Net buying activity: 26 institutions added/increased vs 23 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| First Eagle Investment Management, LLC | 2,606,219 | $765.2M | 16.2% | — |
| BlackRock, Inc. | 1,698,929 | $498.8M | 10.6% | — |
| DIMENSIONAL FUND ADVISORS LP | 944,548 | $277.3M | 5.9% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 826,972 | $242.8M | 5.2% | — |
| ARIEL INVESTMENTS, LLC | 816,751 | $239.8M | 5.1% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 816,198 | $239.6M | 5.1% | — |
| EARNEST PARTNERS LLC | 580,752 | $170.5M | 3.6% | — |
| STATE STREET CORP | 571,762 | $167.9M | 3.6% | — |
| BANK OF AMERICA CORP /DE/ | 490,412 | $144.0M | 3.1% | — |
| Capital World Investors | 462,457 | $135.8M | 2.9% | NEW |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| NOMURA HOLDINGS INC | ADD | 217,342 | 328,897 | +51.3% | $96.6M |
| Assenagon Asset Management S.A. | ADD | 147,834 | 233,227 | +57.8% | $68.5M |
| MORGAN STANLEY | TRIM | 273,931 | 190,285 | -30.5% | $55.9M |
| GOLDMAN SACHS GROUP INC | DOUBLED | 53,040 | 181,225 | +241.7% | $53.2M |
| VICTORY CAPITAL MANAGEMENT INC | DOUBLED | 18,639 | 122,126 | +555.2% | $35.9M |
| ING GROEP NV | ADD | 90,000 | 112,700 | +25.2% | $33.1M |
| Neuberger Berman Group LLC | DOUBLED | 3,029 | 111,812 | +3591.4% | $32.8M |
| NORGES BANK | NEW | — | 111,580 | — | $32.8M |
| WELLS FARGO & COMPANY/MN | DOUBLED | 20,669 | 97,500 | +371.7% | $28.6M |
| FIRST TRUST ADVISORS LP | DOUBLED | 1,522 | 94,209 | +6089.8% | $27.7M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
9 insiders, 50 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 6, 2026 | BARRY JAMES | EVP, President, LSG | EXERCISE | 1,056 | — | — |
| Sep 6, 2026 | Allison Schwartz | Director | EXERCISE | 92 | — | — |
| Sep 6, 2026 | Allison Schwartz | Director | TAX W/H | 34 | $386.11 | $13.1K |
| Sep 6, 2026 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | TAX W/H | 782 | $386.11 | $301.9K |
| Sep 6, 2026 | ENGELHARDT EVA ANETTE | EVP, President, CDG | EXERCISE | 1,152 | — | — |
| Sep 6, 2026 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | EXERCISE | 1,536 | — | — |
| Sep 6, 2026 | SCHWARTZ NORMAN D | Chairman & CEO | EXERCISE | 3,455 | — | — |
| Sep 6, 2026 | EVRAN SEDAT | EVP, Global Supply Chain | TAX W/H | 277 | $386.11 | $107.0K |
| Sep 6, 2026 | BARRY JAMES | EVP, President, LSG | TAX W/H | 470 | $386.11 | $181.5K |
| Sep 6, 2026 | EVRAN SEDAT | EVP, Global Supply Chain | EXERCISE | 864 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for BIO.
Shares short
998,654
Settlement Sep 15, 2026
Change vs prior
-11.7%
Semi-monthly cycle
Days to cover
3.8
At avg daily volume
Of shares outstanding
≈3.7%
Estimate — not % of float
All BIO filing & press-release reports (2)
- COURT-RULING reportSep 12, 2026
- INST-CLUSTER reportJun 12, 2026